Series D startup

Who invested in Weikang Bio

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$14Mraised across 1 round since 2024, from 1 source

Latest round
Series D, $14MJul 2024
Investors
2
See who backed them

The rounds

  1. Jul 2024
    Series D$14M

    Source recorded

Everyone who backed them

China Merchants CapitalVC firm1round
SDIC Venture CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Weikang Bio

Who invested in Weikang Bio?

Weikang Bio's investors include China Merchants Capital and SDIC Venture Capital.

How much has Weikang Bio raised?

Weikang Bio has raised $14M across 1 round since 2024.

When did Weikang Bio last raise?

Weikang Bio's most recent round was a Series D of $14M in Jul 2024.

What was Weikang Bio's biggest round?

Its most recent round, $14M in Jul 2024, is also its largest on record.

Who backed Weikang Bio first?

Weikang Bio's first round on record, in Jul 2024, was backed by China Merchants Capital and SDIC Venture Capital.

What stage is Weikang Bio at?

Weikang Bio's latest named round is a Series D, in Jul 2024.

Companies like Weikang Bio

In the same sector, and raised in the last eighteen months.

Cloverleaf Bio$33M · Sept 2026Cheiron$8.0M · Jul 2026Tavo Biotherapeutics$17M · Jun 2026Countable Labs$26M · May 2026Oricell Therapeutics$180M · Apr 2026Immunofoco$29M · Mar 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app